Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
15,247
datasets available to search
ShareScore release 0.9.0
Dataset results
15,247 results for “Breast cancer;”
Study Of MK-0752 In Combination With Tamoxifen Or Letrozole to Treat Early Stage Breast Cancer
ClinicalTrials.gov study NCT00756717. IPD Sharing: NO. Countries: 1. Publications: 1.
Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer Patients
ClinicalTrials.gov study NCT01814397. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)
ClinicalTrials.gov study NCT01945775. IPD Sharing: YES. Countries: 16. Publications: 3.
Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer.
ClinicalTrials.gov study NCT01298193. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
ClinicalTrials.gov study NCT02102490. IPD Sharing: YES. Countries: 4. Publications: 1.
CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer
ClinicalTrials.gov study NCT02992067. IPD Sharing: NO. Countries: 1. Publications: 1.
Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer
ClinicalTrials.gov study NCT00871858. IPD Sharing: Not stated. Countries: 1. Publications: 2.
F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer
ClinicalTrials.gov study NCT00602043. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer
ClinicalTrials.gov study NCT02657889. IPD Sharing: NO. Countries: 1. Publications: 3.
A Randomized Phase II Study Of Eribulin Mesylate With or Without Pembrolizumab For Metastatic Hormone Receptor Positive Breast Cancer
ClinicalTrials.gov study NCT03051659. IPD Sharing: NO. Countries: 1. Publications: 2.
A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer.
ClinicalTrials.gov study NCT03840200. IPD Sharing: Not stated. Countries: 5. Publications: 1.
A Study of Eribulin Mesylate With Trastuzumab for Advanced or Recurrent Human Epidermal Growth Factor Receptor 2-Positive (HER2+) Breast Cancer
ClinicalTrials.gov study NCT01432886. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
ClinicalTrials.gov study NCT00096356. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT01273610. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients
ClinicalTrials.gov study NCT01625286. IPD Sharing: YES. Countries: 11. Publications: 2.
Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer
ClinicalTrials.gov study NCT01349959. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cardiac Safety Study in Patients With HER2 + Breast Cancer
ClinicalTrials.gov study NCT01904903. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Electrochemotherapy for Chest Wall Recurrence af Breast Cancer: Present Challenges and Future Prospects.
ClinicalTrials.gov study NCT00744653. IPD Sharing: Not stated. Countries: 1. Publications: 1.
FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer
ClinicalTrials.gov study NCT01931709. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
ClinicalTrials.gov study NCT00066690. IPD Sharing: Not stated. Countries: 3. Publications: 13.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.